Editas Medicine

Editas Medicine is a biotechnology company focused on developing therapies using CRISPR gene-editing technology. This innovative approach allows scientists to modify DNA with precision, potentially correcting genetic disorders at their source. By targeting the underlying causes of diseases, such as inherited blindness and certain blood disorders, Editas aims to provide new treatment options that could improve patients' lives. The company's research and development efforts are at the forefront of personalized medicine, promising breakthroughs that could transform how we treat genetic conditions.